FIELD: medicine.
SUBSTANCE: invention relates to a method of the determination and detection of saquinavir and ritonavir in biological fluids. A method of determination and detection in urine, plasma or saliva of saquinavir and ritonavir in combinations with tenofovir, lopinavir, isoniazid, phenazepam, diazepam, phenobarbital, cinnarizine, picamilon by chromatography in a thin layer of a sorbent on Sorbfil plates of a solution of analytes and standard samples of substances-witnesses, while preparing the test solution by isolating the substances to be determined from 10 ml of urine, plasma, saliva, 30 ml of butyl acetate and 10 ml of sodium chloride solution 20% at pH 3.0, chromatography is carried out in a thin layer of the sorbent in the solvent system ethyl acetate — acetone — ethanol 95% — glacial acetic acid with a solvent ratio of 40:40:2:1 by volume and the detection of zones of substances on a chromatogram in UV light.
EFFECT: above invention makes it possible to determine saquinavir and ritonavir isolated from biological fluids with butyl acetate and 20% sodium chloride solution at pH 3 by chromatography and UV light detection.
1 cl, 1 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR DETERMINING AND DETECTING ANTIRETROVIRAL COMBINED DRUGS IN URINE | 2017 |
|
RU2655804C1 |
METHOD FOR DETECTION IN URINE OF FLUORINE-CONTAINING DRUGS IN COMBINATIONS | 2019 |
|
RU2710259C1 |
COMBINATION OF ANTI-HIV INHIBITORS OF REVERSE TRANSCRIPTASE AND PROTEASE | 2005 |
|
RU2368380C2 |
SOLID PHARMACEUTICAL COMPOSITION FOR MANUFACTURING ORAL ANTIRETROVIRAL THERAPEUTIC AGENT | 2020 |
|
RU2760129C1 |
PHARMACEUTICAL COMPOSITIONS CONTAINING ANTIRETROVIRAL DRUG AND PHARMACOKINETICS IMPROVER | 2017 |
|
RU2745204C2 |
PHARMACEUTICAL COMPOSITION FOR TREATING HIV-INFECTION, METHOD FOR PREPARING AND METHOD OF USING | 2013 |
|
RU2543322C1 |
PHARMACEUTICAL COMPOSITION FOR TREATING HIV INFECTION, METHOD FOR PREPARING IT, AND METHOD OF TREATING | 2012 |
|
RU2505286C1 |
PHARMACEUTICAL COMPOSITION HAVING ANTI-HIV INFECTION ACTIVITY | 2017 |
|
RU2659693C1 |
METHODS AND COMPOSITIONS FOR TREATING HIV INFECTION | 2005 |
|
RU2367439C2 |
METHOD AND COMPOSITION FOR PREVENTING HIV INFECTION, PREVENTING AND TREATING HIV-CAUSED OR HIV-ASSOCIATED DISEASES, INCLUDING AIDS | 2010 |
|
RU2516931C2 |
Authors
Dates
2023-07-31—Published
2022-10-24—Filed